Abstract
Insulin-like growth factors (IGFs) stimulate proliferation and differentiation of
PC12 rat pheochromocytoma cells and modulate catecholamine release in bovine adrenal
medullary cells. Dexamethasone increases catecholamine synthesis in PC12 cells. We
therefore studied the effects of IGFs and dexamethasone on catecholamine content in
PC12 cells. Dopamine (DA) and norepinephrine (NE) content of PC12 cells were measured
after incubation for 72 h with IGFs (100 ng/ml) and/or dexamethasone (500 nM). IGF-I
(100 ng/ml) and IGF-II (100 ng/ml) decreased DA and NE content to ∼ 35 % and ∼ 25
% of control, respectively. [Leu27]IGF-II, which binds to the IGF-I receptor with markedly decreased affinity, did not
reduce catecholamine levels, indicating that the effect is likely to be mediated by
the IGF-I receptor. Dexamethasone (500 nM) increased levels of DA and NE to 173 ±
20 % and 331 ± 48 % of controls, respectively. Coincubation with IGFs did not significantly
affect the stimulation of DA by dexamethasone, but abolished the rise in NE. Levels
of tyrosine hydroxylase mRNA, protein and activity were increased following incubation
with dexamethasone, but were unchanged by IGFs. These results indicate that IGFs decrease
catecholamine content in PC12 cells via the IGF-I receptor. Complex regulation involving multiple synthetic and/or degradative
steps is implicated in this process.
Key words
Adrenal Medulla - Dopamine - Norepinephrine - Dexamethasone - Tyrosine Hydroxylase
- Pheochromocytoma
References
- 1
Greene L A, Tischler A S.
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells
which respond to nerve growth factor.
Proc Natl Acad Sci USA.
1976;
73
2424-2428
- 2
Tischler A S, Perlman R L, Morse G M, Sheard B E.
Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma
cell cultures.
J Neurochem.
1983;
40
364-370
- 3
Kim K-T, Park D H, Joh T H.
Parallel up-regulation of catecholamine biosynthetic enzymes by dexamethasone in PC12
cells.
J Neurochem.
1993;
60
946-951
- 4
Jones J I, Clemmons D R.
Insulin-like growth factors and their binding proteins: biological actions.
Endocr Rev.
1995;
16
3-34
- 5
Nielsen F C, Gammeltoft S.
Insulin-like growth factor are mitogens for rat pheochromocytoma PC 12 cells.
Biochem Biophys Res Commun.
1988;
154
1018-1023
- 6
Dahmer M K, Ji L, Perlman R L.
Characterization of insulin-like growth factor-I receptors in PC12 pheochromocytoma
cells and bovine adrenal medulla.
Journal of Neurochemistry.
1989;
53
1036-1042
- 7
Dahmer M K, Perlman R L.
Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis
in PC12 pheochromocytoma cells.
Endocrinology.
1988;
122
2109-2113
- 8
Rukenstein A, Rydel R E, Greene L A.
Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent
mechanisms.
J Neurosci.
1991;
11
2552-2563
- 9
Ren J, Samson W K, Sowers J R.
Insulin-like growth factor I as a cardiac hormone: Physiological and pathophysiological
implications in heart disease.
J Mol Cell Cardiol.
1999;
31
2049-2061
- 10
Dahmer M K, Hart P M, Perlman R L.
Studies on the effect of insulin-like growth factor-I on catecholamine secretion from
chromaffin cells.
J Neurochem.
1990;
54
931-936
- 11
Dahmer M K, Hart P M, Perlman R L.
Insulin-like growth factor-I enhances tyrosine hydroxylase activation in bovine chromaffin
cells.
J Neurochem.
1991;
57
1347-1353
- 12
Hwang O, Choi H J.
Induction of gene expression of the catecholamine-synthesizing enzymes by insulin-like
growth factor I.
J Neurochem.
1995;
65
1988-1996
- 13
Youdim M B.
PC12 cells as a window for the differentiation of neural crest into adrenergic nerve
ending and adrenal medulla.
J Neural Transm Suppl.
1991;
34
61-67
- 14
Byrd J C, Hadjiconstantinou M, Cavalla D.
Epinephrine synthesis in the PC12 pheochromocytoma cell line.
Eur J Pharmacol.
1986;
127
139-142
- 15
Bach L A, Leeding K S, Leng S L.
Regulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma
cells.
J Endocrinol.
1997;
155
225-232
- 16
Hjemdahl P.
Catecholamine measurements by high-performance liquid chromatography.
Am J Physiol.
1984;
247
E13-E20
- 17
Grima B, Lamouroux A, Blanot F, Biguet F, Mallet J.
Complete coding sequence of rat tyrosine hydroxylase mRNA.
Proc Natl Acad Sci USA.
1985;
82
617-621
- 18
Quinsey N S, Lenaghan C M, Dickson P W.
Identification of Gln313 and Pro327 as residues critical for substrate inhibition
in tyrosine hydroxylase.
J Neurochem.
1996;
66
908-914
- 19
Sakano K, Enjoh T, Numata F, Fujiwarah H, Marumoto Y, Higashihashi N, Sato Y, Perdue J F,
Fujita-Yamaguchi Y.
The design, expression, and characterization of human insulin-like growth factor II
(IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate
receptor or IGF-I receptor.
J Biol Chem.
1991;
266
20 626-20 635
- 20
Huang C M, Kao L S.
Nerve growth factor, epidermal growth factor, and insulin differentially potentiate
ATP-induced [Ca2+]i rise and dopamine secretion in PC12 cells.
J Neurochem.
1996;
66
124-130
- 21
Bitar M S, Francis I M, Pilcher C WT.
Insulin-like growth factor 1-induced alterations in lumbospinal monoamine dynamics.
Horm Metab Res.
2000;
32
207-215
- 22
Wilson S P.
Insulin-like growth factor I enhances proenkephalin synthesis and dopamine b-hydroxylase
activity in adrenal chromaffin cells.
Life Sci.
1991;
49
269-272
- 23
Youdim M B, Heldman E, Pollard H B, Fleming P, McHugh E.
Contrasting monoamine oxidase activity and tyramine induced catecholamine release
in PC12 and chromaffin cells.
Neuroscience.
1986;
19
1311-1318
- 24
Bach L A, Tseng L Y-H, Swartz J E, Rechler M M.
Rat PC12 pheochromocytoma cells synthesize insulin-like growth factor-binding protein-6.
Endocrinology.
1993;
133
990-995
- 25
Bach L A, Hsieh S, Sakano K, Fujiwarah H, Perdue J F, Rechler M M.
Binding of mutants of human insulin-like growth factor II to insulin-like growth factor
binding proteins 1 - 6.
J Biol Chem.
1993;
268
9246-9254
- 26
McMahon A, Sabban E L.
Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids
and cyclic AMP analogues.
J Neurochem.
1992;
59
2040-2047
- 27
Donath M Y, Sutsch G, Yan X W, Piva B, Brunner H P, Glatz Y, Zapf J, Follath F, Froesch E R,
Kiowski W.
Acute cardiovascular effects of insulin-like growth factor I in patients with chronic
heart failure.
J Clin Endocrinol Metab.
1998;
83
3177-3183
- 28
Donath M Y, Jenni R, Brunner H-P, Anrig M, Kohli S, Glatz Y, Froesch E R.
Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during
exercise in humans.
J Clin Endocrinol Metab.
1996;
81
4089-4094
L. Bach, Associate Professor
Department of Medicine, University of Melbourne ·
Austin & Repatriation Medical Centre · Studley Road · Heidelberg, Victoria 3084 ·
Australia
Phone: + 61-3-94 96 35 81
Fax: + 61-3-94 57 54 85
Email: l.bach@unimelb.edu.au.